991 results on '"Haneda, Masakazu"'
Search Results
2. Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan
3. Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan
4. Prospective study on clinical characteristics of Japanese diabetic patients with chronic limb-threatening ischemia presenting Fontaine stage IV
5. Cost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian subpopulation in the EMPA-REG OUTCOME Trial
6. N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR ≥ 30 ml/min/1.73 m2
7. Clinical characteristics of Japanese diabetic patients with critical limb ischemia presenting Fontaine stage IV
8. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial
9. Association between all-cause mortality and severity of depressive symptoms in patients with type 2 diabetes: Analysis from the Japan Diabetes Complications Study (JDCS)
10. Relationship of Eating Patterns and Metabolic Parameters, and Teneligliptin Treatment: Interim Results from Post-marketing Surveillance in Japanese Type 2 Diabetes Patients
11. Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance
12. Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis
13. Japanese Clinical Practice Guideline for Diabetes 2016
14. Sex differences in risk factors for end‐stage kidney disease and death in type 2 diabetes: A retrospective cohort study
15. Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials
16. Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus
17. Glycemic targets for elderly patients with diabetes
18. Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test
19. Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: report of Committee on Causes of Death in Diabetes Mellitus
20. New glycemic targets for patients with diabetes from the Japan Diabetes Society
21. Correction to: Japanese Clinical Practice Guideline for Diabetes 2016
22. Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA‐T2D trial
23. PPAR-γ Ligands and Diabetic Nephropathy
24. Has the safety of diabetes therapy improved? Lessons from an analysis of diabetic medication-induced severe hypoglycemic cases in an emergency department from 2005 to 2013
25. Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1–30) expression is upregulated in diabetes and PEGylated GIP(1–30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice
26. Risk factors associated with abnormal cognition in Japanese outpatients with diabetes, hypertension or dyslipidemia
27. Altered Unfolded Protein Response Is Implicated in the Age-Related Exacerbation of Proteinuria-Induced Proximal Tubular Cell Damage
28. Evidence-based practice guideline for the treatment for diabetes in Japan 2013
29. Efficacy and Safety of Empagliflozin Monotherapy for 52 Weeks in Japanese Patients with Type 2 Diabetes: A Randomized, Double-Blind, Parallel-Group Study
30. A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
31. Correction to: Japanese Clinical Practice Guideline for Diabetes 2016
32. The effects of blood pressure control levels on the renoprotection of type 2 diabetic patients without overt proteinuria
33. A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
34. Diabetic nephropathy and transcription factors
35. Association between serum soluble TNFα receptors and renal dysfunction in type 2 diabetic patients without proteinuria
36. Contribution of glimepiride to basal–prandial insulin therapy in patients with type 2 diabetes
37. Clinical practice of diabetic foot, nephropathy, and retinopathy in Japan: cross-sectional study using local and nationwide questionnaire surveys
38. Risk Factor for Progression of Microalbuminuria in Relatively Young NIDDM-Patients
39. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes
40. Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial
41. Alternative form of glucose-dependent insulinotropic polypepide and its physiology
42. Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure)
43. Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation
44. Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus
45. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design
46. Extracellular RNA transfer from non‐malignant human cholangiocytes can promote cholangiocarcinoma growth
47. A note from the new Editor-in-Chief
48. Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus
49. Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-β 1 enhanced IL-18 expression in human renal proximal tubular epithelial cells
50. Serum indoxyl sulfate levels in patients with diabetic nephropathy: Relation to renal function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.